186 related articles for article (PubMed ID: 16146747)
1. Primary gastrointestinal stromal tumor of the liver with lung metastases successfully treated with STI-571 (imatinib mesylate).
De Chiara A; De Rosa V; Lastoria S; Franco R; Botti G; Iaffaioli VR; Apice G
Front Biosci; 2006 Jan; 11():498-501. PubMed ID: 16146747
[TBL] [Abstract][Full Text] [Related]
2. An unusual and potentially misleading phenotypic change in a primary gastrointestinal stromal tumour (GIST) under imatinib mesylate therapy.
Vassos N; Agaimy A; Schlabrakowski A; Hohenberger W; Schneider-Stock R; Croner RS
Virchows Arch; 2011 Mar; 458(3):363-9. PubMed ID: 21191613
[TBL] [Abstract][Full Text] [Related]
3. [A case of liver and bone metastasis from gastrointestinal stromal tumor treated using imatinib].
Murakami M; Ebisui C; Okada K; Okamura S; Murata K; Nakagomi N; Tamai M; Kinuta M
Gan To Kagaku Ryoho; 2014 Jan; 41(1):99-101. PubMed ID: 24423961
[TBL] [Abstract][Full Text] [Related]
4. Effect of imatinib mesylate in a patient with a metastatic gastrointestinal stromal tumor with a c-kit mutation in exon 11.
Kubota K; Katayama A; Takeshita Y; Nozaki K; Ueda T; Imamura K; Hiki N; Nomura S; Kaminishi M; Mafune K
Dig Dis Sci; 2007 Jul; 52(7):1725-9. PubMed ID: 17546507
[No Abstract] [Full Text] [Related]
5. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
[TBL] [Abstract][Full Text] [Related]
6. Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy.
Annaberdyev S; Gibbons J; Hardacre JM
World J Surg Oncol; 2009 Mar; 7():30. PubMed ID: 19291285
[TBL] [Abstract][Full Text] [Related]
7. Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene.
Yamaguchi M; Matsumoto T; Tate G; Higuchi T
J Gastroenterol; 2004 Sep; 39(9):904-5. PubMed ID: 15565413
[No Abstract] [Full Text] [Related]
8. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
Valls-Ferrusola E; García-Garzón JR; Ponce-López A; Soler-Peter M; Fuertes-Cabero S; Moragas-Solanes M; Riera-Gil E; Carrió-Gasset I; Lomeña-Caballero F
Rev Esp Enferm Dig; 2012 Jul; 104(7):360-6. PubMed ID: 22849497
[TBL] [Abstract][Full Text] [Related]
9. Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.
Heinicke T; Wardelmann E; Sauerbruch T; Tschampa HJ; Glasmacher A; Palmedo H
Anticancer Res; 2005; 25(6C):4591-4. PubMed ID: 16334147
[TBL] [Abstract][Full Text] [Related]
10. Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment.
Ulusan S; Koç Z; Kayaselçuk F
Turk J Gastroenterol; 2008 Jun; 19(2):129-32. PubMed ID: 19110671
[TBL] [Abstract][Full Text] [Related]
11. Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate.
Colović R; Micev M; Matić S; Colović N; Grubor N; Atkinson HD
Vojnosanit Pregl; 2013 Feb; 70(2):225-8. PubMed ID: 23607193
[TBL] [Abstract][Full Text] [Related]
12. Primary GIST of the liver masquerading as primary intra-abdominal tumour: a rare extra-gastrointestinal stromal tumour (EGIST) of the liver.
Louis AR; Singh S; Gupta SK; Sharma A
J Gastrointest Cancer; 2014 Sep; 45(3):392-4. PubMed ID: 23749608
[No Abstract] [Full Text] [Related]
13. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors.
De Giorgi U; Aliberti C; Benea G; Conti M; Marangolo M
Clin Cancer Res; 2005 Sep; 11(17):6171-6. PubMed ID: 16144917
[TBL] [Abstract][Full Text] [Related]
14. [A case of imatinib-resistant GIST treated by sunitinib].
Sakamoto Y; Akimoto H; Kojo M; Kawano H; Chinen Y; Morita K; Sugiyama M; Saeki H; Minami K; Soejima Y; Sakaguchi Y; Toh Y; Okamura T
Gan To Kagaku Ryoho; 2011 May; 38(5):827-30. PubMed ID: 21566447
[TBL] [Abstract][Full Text] [Related]
15. Pathological complete response in advanced gastrointestinal stromal tumor after imatinib therapy.
Melichar B; Voboril Z; Nozicka J; Ryska A; Urminská H; Vanecek T; Michal M
Intern Med; 2005 Nov; 44(11):1163-8. PubMed ID: 16357454
[TBL] [Abstract][Full Text] [Related]
16. [A resected case of postoperative liver metastasis of a gastrointestinal stromal tumor showing complete response after imatinib treatment].
Yamamura M; Hirai T; Higashida M; Kubota H; Murakami H; Kawabe Y; Ikeda M; Hirabayashi Y; Okawaki M; Hironaka K; Oka Y; Okumura H; Akiyama T; Matsumoto H; Urakami A; Yamashita K; Yamaguchi Y; Tsunoda T
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1945-9. PubMed ID: 19011349
[TBL] [Abstract][Full Text] [Related]
17. High-risk CD117-positive gastrointestinal stromal tumor of the colon in a 12-year-old girl: adjuvant treatment with imatinib mesylate.
Okur A; Oguz A; Karadeniz C; Pinarli FG; Ozen O; Ekinci O
Tumori; 2012; 98(2):59e-62e. PubMed ID: 22678007
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
19. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
Zheng S; Jia J; Pan YL; Tao DY; Lu HS
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):42-3. PubMed ID: 23611272
[No Abstract] [Full Text] [Related]
20. Development of multiple myeloma in a patient with gastrointestinal stromal tumor treated with imatinib mesylate: a case report.
Tzilves D; Gatopoulou A; Zervas K; Katodritou E; Patakiouta F; Tarpagos A; Katsos I
World J Gastroenterol; 2007 Apr; 13(13):2011-3. PubMed ID: 17461509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]